Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 37 citing Allen: Halofenate is a selective peroxisome proliferator–activated receptor γ modulator.... (0.08 sec) 

PPAR dual agonists: are they opening Pandora's Box?


P Balakumar, M Rose, SS Ganti, P Krishan, M … - Pharmacological Research, 2007 - Elsevier
Cardiovascular disorders are the major cause of mortality in patients of
diabetes mellitus. Peroxisome proliferator activated receptors (PPARs) are
ligand-activated transcription factors of nuclear hormone receptor ...
Cited by 49 - Related articles - All 3 versions

[PDF] Selective modulators of PPAR-γ activity: molecular aspects related to obesity and side- …


F Zhang, BE Lavan, FM Gregoire… - PPAR research, 2007 - hindawi.com
Page 1. Hindawi Publishing Corporation PPAR Research Volume 2007, Article
ID 32696, 7 pages doi:10.1155/2007/32696 Review Article ...
Cited by 37 - Related articles - View as HTML - All 10 versions

Molecular basis of selective PPARγ modulation for the treatment of type 2 diabetes


L Gelman, JN Feige, B Desvergne - BBA-Molecular and Cell Biology of Lipids, 2007 - Elsevier
Peroxisome proliferator-activated receptors (PPARs) (α, β/δ and γ) are lipid
sensors capable of adapting gene expression to integrate various lipid signals.
As such, PPARs are also very important pharmaceutical targets, and specific ...
Cited by 19 - Related articles - All 3 versions

Fat poetry: a kingdom for PPARγ


SI Anghel, W Wahli - Cell Research, 2007 - nature.com
Adipose tissue is not an inert cell mass contributing only to the storage of
fat, but a sophisticated ensemble of cellular components with highly specialized
and complex functions. In addition to managing the most important energy ...
Cited by 17 - Related articles - BL Direct - All 6 versions

[PDF] The Treatment of Dyslipidemia-What's Left in the Pipeline?


O Rau, H Zettl, L Popescu, D Steinhilber, M … - ChemMedChem, 2008 - tu-darmstadt.de
Dyslipidemia is a pathological increase of lipid and lipoprotein levels in the
blood. Most prominent among these are the hy- perlipidemic diseases
hypercholesterolemia and hypertriglycer- idemia. Elevated levels of ...
Cited by 9 - Related articles - View as HTML - All 5 versions

S 26948

- mendeley.com [PDF] 
MC Carmona, K Louche, B Lefebvre, A Pilon, N … - Diabetes, 2007 - Am Diabetes Assoc
RESULTS—S 26948 displayed pharmacological features of a high selective ligand
for PPARγ with low potency in promoting adipocyte differentiation. It also
displayed a different coactivator recruitment profile compared with ...
Cited by 8 - Related articles - BL Direct - All 4 versions

PPAR modulators and PPAR pan agonists for metabolic diseases: the next generation of …


PL Feldman, MH Lambert, BR Henke - Current Topics in Medicinal Chemistry, 2008 - ingentaconnect.com
Page 1. 728 Current Topics in Medicinal Chemistry, 2008, 8, 728-749
1568-0266/08 $55.00+.00 © 2008 Bentham Science Publishers Ltd. ...
Cited by 8 - Related articles - BL Direct - All 2 versions

[PDF] Peroxisome proliferators-activated receptor (PPAR) modulators and metabolic disorders


MC Cho, K Lee, SG Paik, DY Yoon - PPAR research, 2008 - downloads.hindawi.com
Hindawi Publishing Corporation PPAR Research Volume 2008, Article ID 679137, 14
pages doi:10.1155/2008/679137 ... Min-Chul Cho,1 Kyoung Lee,2 Sang-Gi Paik,3
and Do-Young Yoon1 ... 1 Department of Bioscience & Biotechnology, Konkuk ...
Cited by 8 - Related articles - View as HTML - All 9 versions

Adipose Tissue Integrity as a Prerequisite for Systemic Energy Balance

- shouxi.net
SI Anghel, E Bedu, CD Vivier, P Descombes, … - Journal of Biological Chemistry, 2007 - ASBMB
Peroxisome proliferator-activated receptor γ (PPARγ) is an essential regulator
of adipocyte differentiation, maintenance, and survival. Deregulations of its
functions are associated with metabolic diseases. We show here that ...
Cited by 7 - Related articles - All 5 versions

β-Cryptoxanthin, a novel natural RAR ligand, induces ATP-binding cassette transporters …


A Matsumoto, H Mizukami, S Mizuno, K … - Biochemical pharmacology, 2007 - Elsevier
Despite its serious adverse effects, recent accumulating evidence suggests that
a physiological retinoic acid receptor (RAR) agonist, all-trans retinoic acid
(atRA), exhibits preventive effects on atherogenesis. Therefore, the ...
Cited by 6 - Related articles - All 4 versions


Result Page: 

1

2

3

4

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google